CogniCurrent Icon

COGNICURRENT

A compact global news feed for the bigger picture.

⌕
Regions
Topics
Saved views:
Save your current filters to revisit or share.
1 stories
🇬🇷 Naftemporiki
National & Local

Kos Biotechnology financed the biopharmaceutical Epikast

Kos Biotechnology Partners has completed a funding round for the New York-based biopharmaceutical company Epikast, which has key operations in Athens.

Feb 16 • 15:06 UTC

Story in context

Loading Intelligence...

📡

Select a report from the feed to view analysis and related coverage.